Penserra Capital Management LLC Has $1.09 Million Stock Position in Global Medical REIT Inc. (NYSE:GMRE)

Penserra Capital Management LLC increased its position in shares of Global Medical REIT Inc. (NYSE:GMRE) by 22.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 109,844 shares of the company’s stock after acquiring an additional 20,460 shares during the quarter. Penserra Capital Management LLC owned 0.17% of Global Medical REIT worth $1,088,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Gordian Capital Singapore Pte Ltd purchased a new position in shares of Global Medical REIT during the second quarter valued at $100,000. Intech Investment Management LLC purchased a new position in Global Medical REIT during the 3rd quarter valued at about $150,000. Versor Investments LP purchased a new position in Global Medical REIT during the 3rd quarter valued at about $189,000. M&G PLC acquired a new position in shares of Global Medical REIT in the 3rd quarter valued at about $193,000. Finally, First Trust Direct Indexing L.P. lifted its position in shares of Global Medical REIT by 25.6% in the third quarter. First Trust Direct Indexing L.P. now owns 20,432 shares of the company’s stock worth $202,000 after purchasing an additional 4,164 shares in the last quarter. Hedge funds and other institutional investors own 57.52% of the company’s stock.

Global Medical REIT Stock Performance

GMRE opened at $8.80 on Wednesday. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. The stock’s 50 day moving average price is $9.29 and its two-hundred day moving average price is $9.24. The firm has a market capitalization of $587.87 million, a P/E ratio of -440.00, a price-to-earnings-growth ratio of 1.50 and a beta of 1.25. Global Medical REIT Inc. has a 12-month low of $7.98 and a 12-month high of $11.59.

Global Medical REIT (NYSE:GMRE) last announced its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.18). Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. The company had revenue of $34.26 million for the quarter, compared to the consensus estimate of $34.88 million. During the same period last year, the firm posted $0.23 EPS. On average, equities analysts forecast that Global Medical REIT Inc. will post 0.83 earnings per share for the current year.

Global Medical REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, October 8th. Investors of record on Friday, September 20th were given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 9.55%. The ex-dividend date was Friday, September 20th. Global Medical REIT’s dividend payout ratio (DPR) is presently -4,200.00%.

Analyst Ratings Changes

GMRE has been the topic of a number of research analyst reports. Alliance Global Partners began coverage on shares of Global Medical REIT in a research report on Thursday, September 19th. They set a “buy” rating and a $12.00 price objective on the stock. Berenberg Bank initiated coverage on shares of Global Medical REIT in a report on Friday, October 18th. They set a “buy” rating and a $11.75 price target on the stock.

Global Medical REIT Profile

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.